Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury

Circulation

Volumn 114, Issue 5, 2006, Pages 430-437

  Maffia, Pasquale ^a,b   Grassia, Gianluca ^a   Di Meglio, Paola ^a   Carnuccio, Rosa ^a   Berrino, Liberato ^c   Garside, Paul ^d   Ianaro, Angela ^a   Ialenti, Armando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Angioplasty; Balloon; Carotid arteries; Interleukins

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA; ACTIN; INTERLEUKIN 8; SMOOTH MUSCLE ACTIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; BALLOON EMBOLIZATION; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; EMBOLECTOMY; ENDOTHELIUM CELL; IMMUNOREACTIVITY; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; ANIMAL; BALLOON OCCLUSION; BLOOD; CARDIOVASCULAR DISEASE; CAROTID ARTERY INJURY; CELL MOTION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ACTINS; ANIMALS; BALLOON OCCLUSION; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; TUNICA INTIMA;

EID: 33747091335     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.602714     Document Type: Article

References (30)

1. McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther. 2005;7:38-41.
2. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002;195:245-257.
3. Sahar S, Dwarakanath RS, Reddy MA, Lanting L, Todorov I, Natarajan R. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Circ Res. 2005;96:1064-1071.
4. Chandrasekar B, Mummidi S, Valente AJ, Patel DN, Bailey SR, Freeman GL, Hatano M, Tokuhisa T, Jensen LE. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, IRAK, TRAF6, c-Src, PI3 K, Akt, JNK, and AP-1 signaling. J Biol Chem. 2005;280:26263-26277.
5. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001;104:1598-1603.
6. Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-γ. Circ Res. 2002;90:e34-e38.
7. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 2001;89:e41-e45.
8. Korshunov VA, Nikonenko TA, Tkachuk VA, Brooks A, Berk BC. Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 2006;26:295-300.
9. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, Kurimoto M, Tamura J, Kurabayashi M. Interleukin 18 in acute myocardial infarction. Heart. 2000;84:668.
10. Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, Chvatchko Y, Tedgui A. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart. 2002;88:467-469.
11. Zaremba J, Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci. 2003;24:117-124.
12. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Okamura H, Iwasaki T. Increased circulating interleukin-18 in patients with congestive heart failure. Heart. 2002;88:296-297.
13. Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail. 2002;8:21-27.
14. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ, for the AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24-30.
15. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, Nagai Y, Hori M. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol. 2005;25:1-5.
16. Kawasaki D, Tsujino T, Morimoto S, Fujioka Y, Naito Y, Okumura T, Masutani M, Shimizu H, Yuba M, Ueda A, Ohyanagi M, Kashiwamura S, Okamura H, Iwasaki T. Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty. Am J Cardiol. 2003;91:1258-1261.
17. Indolfi C, Torella D, Coppola C, Stabile E, Esposito G, Curcio A, Pisani A, Cavuto L, Arcucci O, Cireddu M, Troncone G, Chiariello M. Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol. 2002;283:H760-H767.
18. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valante AJ. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappa B- and AP-1-mediated matrix metalloproteinase-9 expression, and is inhibited by atorvastatin. J Biol Chem. 2006;281:15099-15109.
19. Maffia P, Ianaro A, Sorrentino R, Lippolis L, Macello FM, del Soldato P, Ialenti A, Cirino G. Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis. Arterioscler Thromb Vasc Biol. 2002;22:263-267.
20. Di Meglio P, Ianaro A, Ghosh S. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 2005;52:951-958.
21. Ye XJ, Tang B, Ma Z, Kang AH, Myers LK, Cremer MA. The roles of interleukin-18 in collagen-induced arthritis in the BB rat. Clin Exp Immunol. 2004;136:440-447.
22. Maffia P, Brewer JM, Gracie JA, Ianaro A, Leung BP, Mitchell PJ, Smith KM, McInnes IB, Garside P. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol. 2004;173:151-156.
23. Narins CR, Lin DA, Burton PB, Jin ZG, Berk BC. Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction. Am J Cardiol. 2004;94:1285-1287.
24. Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE, Mummidi S. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J Biol Chem. 2004;279:20221-20233.
25. Bu D, Erl W, de Martin R, Hansson GK, Yan Z. IKKβ-dependent NF-κB pathway controls vascular inflammation and intimal hyperplasia. FASEB J. 2005;19:1293-1295.
26. Dinarello CA. Interleukin-18: a proinflammatory cytokine. Eur Cytokine Netw. 2000;11:483-486.
27. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Pomerantz BJ, McIntyre RC, Harken AH, Meng X. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol. 2002;283:H650-H657.
28. de Nooijer R, von der Thusen JH, Verkleij CJN, Kuiper J, Jukema JW, van der Wall EE, van Berkel TJC, Biessen EAL. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-e-deficient mice. Arterioscler Thromb Vasc Biol. 2004;24:2313-2319.
29. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today. 2000;21:312-315.
30. Collins T, Cybulsky MI. NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 2001;107:255-264.